ALX1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA001598

Antibody HPA018905

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant tissues displayed weak to moderate nuclear immunoreactivity, often accompanied with faint cytoplasmic staining. Moderate to strong nuclear and/or cytoplasmic positivity was observed in a majority of malignancies. Malignant lymphomas, testicular, urothelial and several lung cancers were negative.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected